- Home
- PKOH vs VNDA Comparison
PKOH vs VNDA Comparison
Compare PKOH & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKOH
- VNDA
- Stock Information
- Founded
- PKOH 1907
- VNDA 2002
- Country
- PKOH United States
- VNDA United States
- Employees
- PKOH N/A
- VNDA N/A
- Industry
- PKOH Industrial Specialties
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- PKOH Industrials
- VNDA Health Care
- Exchange
- PKOH Nasdaq
- VNDA Nasdaq
- Market Cap
- PKOH 299.9M
- VNDA 249.4M
- IPO Year
- PKOH N/A
- VNDA 2006
- Fundamental
- Price
- PKOH $18.70
- VNDA $4.41
- Analyst Decision
- PKOH
- VNDA Strong Buy
- Analyst Count
- PKOH 0
- VNDA 3
- Target Price
- PKOH N/A
- VNDA $14.00
- AVG Volume (30 Days)
- PKOH 22.8K
- VNDA 682.0K
- Earning Date
- PKOH 11-05-2025
- VNDA 10-29-2025
- Dividend Yield
- PKOH 2.68%
- VNDA N/A
- EPS Growth
- PKOH 30.26
- VNDA N/A
- EPS
- PKOH 1.68
- VNDA N/A
- Revenue
- PKOH $1,592,500,000.00
- VNDA $212,074,000.00
- Revenue This Year
- PKOH $0.23
- VNDA $14.32
- Revenue Next Year
- PKOH $3.07
- VNDA $37.05
- P/E Ratio
- PKOH $11.10
- VNDA N/A
- Revenue Growth
- PKOH N/A
- VNDA 11.12
- 52 Week Low
- PKOH $15.52
- VNDA $3.81
- 52 Week High
- PKOH $34.50
- VNDA $5.70
- Technical
- Relative Strength Index (RSI)
- PKOH 37.85
- VNDA 34.91
- Support Level
- PKOH $19.62
- VNDA $4.32
- Resistance Level
- PKOH $21.16
- VNDA $4.51
- Average True Range (ATR)
- PKOH 0.80
- VNDA 0.23
- MACD
- PKOH -0.10
- VNDA -0.13
- Stochastic Oscillator
- PKOH 12.68
- VNDA 9.44
About PKOH Park-Ohio Holdings Corp.
Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.